Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatoshi Kitagawa

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Current Cancer Drug Targets|January 22, 2016
Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer TherapyMasatoshi Kitagawa
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Proteasome-mediated degradation of p53 and RB protein]Masatoshi Kitagawa
Current Drug Targets|October 16, 2012
Editorial: cell cycle control and cell fateMasatoshi Kitagawa
Seikagaku. the Journal of Japanese Biochemical Society|September 27, 2014
[Function of tumor suppressor protein Mig-6 in growth signaling]Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
E3 Ubiquitin Ligases as Molecular Targets in Human Oral CancersKazuma Masumoto, Masatoshi Kitagawa
Current Drug Targets|September 25, 2012
The SCF ubiquitin ligases involved in hematopoietic lineageKyoko Kitagawa, Masatoshi Kitagawa
Current Drug Targets|September 25, 2012
Regulation of DNA replication licensingHiroyuki Niida, Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human CancerChiharu Uchida, Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
The SCF-type E3 Ubiquitin Ligases as Cancer TargetsKyoko Kitagawa, Masatoshi Kitagawa
Cancer Science|May 23, 2009
Ubiquitin-mediated control of oncogene and tumor suppressor gene productsKyoko Kitagawa, Yojiro Kotake, Masatoshi Kitagawa
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Current Cancer Drug Targets|January 22, 2016
Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer TherapyMasatoshi Kitagawa
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Proteasome-mediated degradation of p53 and RB protein]Masatoshi Kitagawa
Current Drug Targets|October 16, 2012
Editorial: cell cycle control and cell fateMasatoshi Kitagawa
Seikagaku. the Journal of Japanese Biochemical Society|September 27, 2014
[Function of tumor suppressor protein Mig-6 in growth signaling]Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
E3 Ubiquitin Ligases as Molecular Targets in Human Oral CancersKazuma Masumoto, Masatoshi Kitagawa
Current Drug Targets|September 25, 2012
The SCF ubiquitin ligases involved in hematopoietic lineageKyoko Kitagawa, Masatoshi Kitagawa
Current Drug Targets|September 25, 2012
Regulation of DNA replication licensingHiroyuki Niida, Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human CancerChiharu Uchida, Masatoshi Kitagawa
Current Cancer Drug Targets|November 13, 2015
The SCF-type E3 Ubiquitin Ligases as Cancer TargetsKyoko Kitagawa, Masatoshi Kitagawa
Cancer Science|May 23, 2009
Ubiquitin-mediated control of oncogene and tumor suppressor gene productsKyoko Kitagawa, Yojiro Kotake, Masatoshi Kitagawa
Pageof 11